Background <p><InlineEquation ID="IEq4"> <EquationSource Format="TEX">\(^{131}\)</EquationSource> <EquationSource Format="MATHML"><math> <mmultiscripts> <mrow /> <mrow /> <mn>131</mn> </mmultiscripts> </math></EquationSource> </InlineEquation>I is a critical radionuclide in nuclear medicine, particularly for thyroid disorder therapies. Chinese national standards mandate reducing <InlineEquation ID="IEq5"> <EquationSource Format="TEX">\(^{131}\)</EquationSource> <EquationSource Format="MATHML"><math> <mmultiscripts> <mrow /> <mrow /> <mn>131</mn> </mmultiscripts> </math></EquationSource> </InlineEquation>I concentrations in radioactive waste liquid to below 10&#xa0;Bq/L. To address this requirement, rapid and precise quantification of <InlineEquation ID="IEq6"> <EquationSource Format="TEX">\(^{131}\)</EquationSource> <EquationSource Format="MATHML"><math> <mmultiscripts> <mrow /> <mrow /> <mn>131</mn> </mmultiscripts> </math></EquationSource> </InlineEquation>I activity is essential for compliance monitoring and clinical safety.</p> Methods <p>A detection system integrating a NaI(Tl) crystal and a silicon photomultiplier array was developed to measure the <InlineEquation ID="IEq7"> <EquationSource Format="TEX">\(^{131}\)</EquationSource> <EquationSource Format="MATHML"><math> <mmultiscripts> <mrow /> <mrow /> <mn>131</mn> </mmultiscripts> </math></EquationSource> </InlineEquation>I concentrations via its 364.5&#xa0;keV characteristic <InlineEquation ID="IEq8"> <EquationSource Format="TEX">\(\gamma \)</EquationSource> <EquationSource Format="MATHML"><math> <mi>γ</mi> </math></EquationSource> </InlineEquation>-ray emissions. The setup incorporates 5&#xa0;cm oxygen-free copper and 5&#xa0;cm lead shielding to mitigate external <InlineEquation ID="IEq9"> <EquationSource Format="TEX">\(\gamma \)</EquationSource> <EquationSource Format="MATHML"><math> <mi>γ</mi> </math></EquationSource> </InlineEquation>-ray interference. Sample analysis utilizes a 50&#xa0;mL aliquot, with system sensitivity evaluated under varying measurement durations.</p> Results <p>Under optimized shielding conditions, the system achieved a minimum detectable activity of 8.0&#xa0;Bq/L for <InlineEquation ID="IEq10"> <EquationSource Format="TEX">\(^{131}\)</EquationSource> <EquationSource Format="MATHML"><math> <mmultiscripts> <mrow /> <mrow /> <mn>131</mn> </mmultiscripts> </math></EquationSource> </InlineEquation>I within a 3-hour measurement period. Extending the acquisition time to 24 hours enhanced sensitivity to 2.8&#xa0;Bq/L, surpassing the regulatory threshold requirement of 10&#xa0;Bq/L.</p> Conclusions <p>The developed system demonstrates sufficient sensitivity and accuracy for monitoring <InlineEquation ID="IEq11"> <EquationSource Format="TEX">\(^{131}\)</EquationSource> <EquationSource Format="MATHML"><math> <mmultiscripts> <mrow /> <mrow /> <mn>131</mn> </mmultiscripts> </math></EquationSource> </InlineEquation>I in radioactive waste liquids, aligning with national emission standards. The time-dependent sensitivity improvement highlights its adaptability for both rapid screening and low-concentration quantification, thus validating its applicability in nuclear medicine waste management.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Developing a Bq/L level \(^{131}\text {I}\) concentration in solution measurement system using NaI(Tl) crystal and SiPM

  • D. Z. Zhang,
  • Q. Tang,
  • X. H. Liang,
  • C. Guo,
  • L. P. Xiang

摘要

Background

\(^{131}\) 131 I is a critical radionuclide in nuclear medicine, particularly for thyroid disorder therapies. Chinese national standards mandate reducing \(^{131}\) 131 I concentrations in radioactive waste liquid to below 10 Bq/L. To address this requirement, rapid and precise quantification of \(^{131}\) 131 I activity is essential for compliance monitoring and clinical safety.

Methods

A detection system integrating a NaI(Tl) crystal and a silicon photomultiplier array was developed to measure the \(^{131}\) 131 I concentrations via its 364.5 keV characteristic \(\gamma \) γ -ray emissions. The setup incorporates 5 cm oxygen-free copper and 5 cm lead shielding to mitigate external \(\gamma \) γ -ray interference. Sample analysis utilizes a 50 mL aliquot, with system sensitivity evaluated under varying measurement durations.

Results

Under optimized shielding conditions, the system achieved a minimum detectable activity of 8.0 Bq/L for \(^{131}\) 131 I within a 3-hour measurement period. Extending the acquisition time to 24 hours enhanced sensitivity to 2.8 Bq/L, surpassing the regulatory threshold requirement of 10 Bq/L.

Conclusions

The developed system demonstrates sufficient sensitivity and accuracy for monitoring \(^{131}\) 131 I in radioactive waste liquids, aligning with national emission standards. The time-dependent sensitivity improvement highlights its adaptability for both rapid screening and low-concentration quantification, thus validating its applicability in nuclear medicine waste management.